| Serial Number | 97464407 |
| Word Mark | CENTAGEN |
| Filing Date | Friday, June 17, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, August 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 19, 2023 |
| Goods and Services | Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations for the treatment of age-related disesases and disorders; Pharmaceutical preparations for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Therapeutic pharmaceutical for the treatment of age-related disesases and disorders; Therapeutic pharmaceutical for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Cardiovascular pharmaceutical preparations |
| Goods and Services | Biochemical research; Biochemical research and development; Biotechnology research; Pharmaceutical research and development; Research and development in the field of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Scientific research; Stem cell research services; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 6, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 6, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Centagen, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80305 |
| Party Name | Centagen, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80305 |
| Event Date | Event Description |
| Tuesday, June 21, 2022 | NEW APPLICATION ENTERED |
| Wednesday, July 6, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 29, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, March 29, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 29, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 29, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 8, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, November 12, 2023 | ASSIGNED TO LIE |
| Monday, November 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, August 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 12, 2024 | SOU EXTENSION 1 FILED |
| Monday, August 12, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, February 13, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |